ERBB2 and obesity due to melanocortin 4 receptor deficiency: In line with previous publications, we found a positive association between both overweight and obesity and risk of ER+ breast cancer, low-grade breast cancer, and with a significant association between obesity and risk of ER+/HER2− and luminal A tumors [5, 9, 36].